Burning Rock Biotech Limited
BNR
$23.00
$0.251.10%
NASDAQ
| 09/30/2025 | 03/31/2025 | 12/31/2024 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | 72.50M | 71.70M | 71.70M | 70.95M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 72.50M | 71.70M | 71.70M | 70.95M |
| Cost of Revenue | -- | 20.67M | 21.33M | 21.33M | 22.19M |
| Gross Profit | -- | 51.83M | 50.38M | 50.38M | 48.76M |
| SG&A Expenses | -- | 52.53M | 62.87M | 62.87M | 74.92M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | 101.84M | 116.48M | 116.48M | 132.26M |
| Operating Income | -- | -29.34M | -44.78M | -44.78M | -61.31M |
| Income Before Tax | -- | -32.25M | -47.33M | -47.33M | -59.08M |
| Income Tax Expenses | -- | 823.80K | 818.10K | 818.10K | 227.70K |
| Earnings from Continuing Operations | -- | -33.07 | -48.14 | -48.14 | -59.31 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -33.07M | -48.14M | -48.14M | -59.31M |
| EBIT | -- | -29.34M | -44.78M | -44.78M | -61.31M |
| EBITDA | -- | -16.66M | -29.29M | -29.29M | -43.05M |
| EPS Basic | -- | -32.04 | -46.82 | -46.82 | -57.83 |
| Normalized Basic EPS | -- | -0.75 | -1.67 | -1.67 | -2.69 |
| EPS Diluted | -- | -32.04 | -46.82 | -46.82 | -57.83 |
| Normalized Diluted EPS | -- | -0.75 | -1.67 | -1.67 | -2.69 |
| Average Basic Shares Outstanding | -- | 41.68M | 41.17M | 41.17M | 41.08M |
| Average Diluted Shares Outstanding | -- | 4.17M | 4.12M | 4.12M | 4.11M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |